Search Results - "Li, Chunrui"

Co-seismic rupture of the 2021, M 7.4 Maduo earthquake (northern Tibet): Short-cutting of the Kunlun fault big bend by Pan, Jiawei, Li, Haibing, Chevalier, Marie-Luce, Tapponnier, Paul, Bai, Mingkun, Li, Chao, Liu, Fucai, Liu, Dongliang, Wu, Kungang, Wang, Ping, Li, Chunrui, Lu, Haijian, Chen, Peng

Get full text

Blocking TRPA1 and TNF-α Signal Improves Bortezomib-Induced Neuropathic Pain by Li, Chunrui, Deng, Taoran, Shang, Zhen, Wang, Di, Xiao, Yi

“…Background/Aims: Bortezomib (BTZ) is largely used as a chemotherapeutic agent for the treatment of multiple myeloma. However, one of the significant limiting…”
Get full text

Viral infection/reactivation during long-term follow-up in multiple myeloma patients with anti-BCMA CAR therapy by Wang, Di, Mao, Xia, Que, Yimei, Xu, Menglei, Cheng, Yuhang, Huang, Liang, Wang, Jue, Xiao, Yi, Wang, Wen, Hu, Guang, Zhang, Shangkun, Zhang, Tongcun, Li, Chunrui, Zhou, Jianfeng

Get full text

PPM1H is down-regulated by ATF6 and dephosphorylates p-RPS6KB1 to inhibit progression of hepatocellular carcinoma by Yang, Xiaoshuang, Guo, Jianting, Li, Wei, Li, Chunrui, Zhu, Xilin, Liu, Ying, Wu, Xiaopan

“…We have shown previously that polymorphism of activating transcription factor 6 (ATF6) is associated with susceptibility to hepatocellular carcinoma (HCC)…”
Get full text

The exploration of B cell maturation antigen expression in plasma cell dyscrasias beyond multiple myeloma by Xu, Yanjie, Mao, Xia, Que, Yimei, Xu, Menglei, Li, Chunhui, Almeida, Varlene Daniela Fernandes, Wang, Di, Li, Chunrui

“…B cell maturation antigen (BCMA) targeted immunotherapies have demonstrated remarkable clinical efficacy in multiple myeloma (MM). Here, we evaluated the BCMA…”
Get full text

The utility of non‐invasive liquid biopsy for mutational analysis and minimal residual disease assessment in extramedullary multiple myeloma by Long, Xiaolu, Xu, Qian, Lou, Yaoyao, Li, Chunrui, Gu, Jia, Cai, Haodong, Wang, Di, Xu, Jinhuan, Li, Tongjuan, Zhou, Xiaoxi, Xiao, Min, Wang, Ying, Mao, Xia, Zhou, Jianfeng, Chen, Liting

Get full text

Postoperative analgesia using dezocine alleviates depressive symptoms after colorectal cancer surgery: A randomized, controlled, double-blind trial by Zhao, Peng, Wu, Zhuoxi, Li, Chunrui, Yang, Guiying, Ding, Jinping, Wang, Kai, Wang, Mingming, Feng, Lijuan, Duan, Guangyou, Li, Hong

“…Postoperative depression is one of the most common mental disorders in patients undergoing cancer surgery and it often delays postoperative recovery. We…”
Get full text

Anti-BCMA CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma Patients With Extramedullary Disease: A Single Center Analysis of Two Clinical Trials by Que, Yimei, Xu, Menglei, Xu, Yanjie, Almeida, Varlene Daniela Fernandes, Zhu, Li, Wang, Zhiqiong, Wang, Ying, Liu, Xian, Jiang, Lijun, Wang, Di, Li, Chunrui, Zhou, Jianfeng

“…The prognosis of relapsed/refractory multiple myeloma (RRMM) patients with the extramedullary disease was significantly poor. Extramedullary multiple myeloma…”
Get full text

Anti-BCMA CAR-T cells for treatment of plasma cell dyscrasia: case report on POEMS syndrome and multiple myeloma by Xu, Jinhuan, Wang, Qiuxiang, Xu, Hao, Gu, Chaojiang, Jiang, Lijun, Wang, Jue, Wang, Di, Xu, Bin, Mao, Xia, Wang, Jin, Wang, Zhiqiong, Xiao, Yi, Zhang, Yicheng, Li, Chunrui, Zhou, Jianfeng

“…POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome still has no standard treatment. On the basis that both…”
Get full text

A novel two-step administration of XPO-1 inhibitor may enhance the effect of anti-BCMA CAR-T in relapsed/refractory extramedullary multiple myeloma by Wang, Di, Fu, Haiying, Que, Yimei, Ruan, Haitao, Xu, Menglei, Long, Xiaolu, Yu, Qiuxia, Li, Chunhui, Li, Zhe, Cai, Songbai, Chen, Wei, Sun, Cong, Hu, Guang, Wang, Shuai, He, Donggou, Mei, Jianming, Wang, Wen, Li, Chunrui

“…Abstract Background Extramedullary disease usually implies a dismal outcome in relapsed/refractory multiple myeloma patients, and requires novel treatment…”
Get full text

Efficacy of programmed cell death 1 inhibitor maintenance after chimeric antigen receptor T cells in patients with relapsed/refractory B-cell non-Hodgkin-lymphoma by Xin, Xiangke, Zhu, Xiaojian, Yang, Yang, Wang, Na, Wang, Jue, Xu, Jinhuan, Wei, Jia, Huang, Liang, Zheng, Miao, Xiao, Yi, Li, Chunrui, Cao, Yang, Meng, Fankai, Jiang, Lijun, Zhang, Yicheng

“…Introduction Chimeric antigen receptor (CAR)-T cells obtained long-term durability in about 30% to 40% of relapsed/refractory (r/r) B-cell non-Hodgkin lymphoma…”
Get full text

Mutations in immunodeficiency-related genes may increase the risk of infection after CAR-T-cell therapy: a report of two cases by Wang, Di, He, Li, Li, Chunhui, Xu, Menglei, Yu, Qiuxia, Almeida, Varlene Daniela Fernandes, Que, Yimei, Xu, Yanjie, Xiao, Yi, Li, Chunrui

“…Chimeric antigen receptor T-cell therapy (CAR-T) has yielded unprecedented efficacy in B-cell malignancies. With the increasing use of CAR-T-cell therapy,…”
Get full text

Identification and Biochemical Properties of Two New Acetylcholinesterases in the Pond Wolf Spider (Pardosa pseudoannulata) by Meng, Xiangkun, Li, Chunrui, Xiu, Chunli, Zhang, Jianhua, Li, Jingjing, Huang, Lixin, Zhang, Yixi, Liu, Zewen

“…Acetylcholinesterase (AChE), an important neurotransmitter hydrolase in both invertebrates and vertebrates, is targeted by organophosphorus and carbamate…”
Get full text

Oligosecretory Waldenström macroglobulinemia exhibits excellent treatment response and outcomes by Xiong, Wenjie, Yu, Ying, Sun, Chunyan, Du, Juan, Cai, Zhen, Wang, Zanzan, Cao, Xinxin, Yan, Yuting, Chen, Jiawen, Huang, Yanshan, Jiang, Zhongxing, Wang, Huihan, Niu, Ting, Yang, Guangzhong, Xue, Hua, Li, Bingzong, Huang, Honghui, Li, Zhenling, Liu, Qinhua, Li, Fei, Bai, Ou, Mao, Min, Fu, Rong, Wang, Ling, Li, Chunrui, Chu, Xiaoxia, Liu, Lihong, Dong, Yujun, Wang, Luqun, Luo, Jun, Wei, Yongqiang, Cui, Rui, Qiu, Lugui, Li, Jian, Yi, Shuhua

Get full text

Effects of Lycium barbarum polysaccharides on the proliferation and differentiation of primary Sertoli cells in young rats by Suqin Hu, Chunrui Li, Dianlong Liu, Jian Guo

“…Objective: Sertoli cells (SCs) provide physical support and material supply for germ cells and participate in the formation of blood-testis barrier. The number…”
Get full text

Immunological alternation in COVID-19 patients with cancer and its implications on mortality by Cai, Guangyao, Gao, Yue, Zeng, Shaoqing, Yu, Yang, Liu, Xingyu, Liu, Dan, Wang, Ya, Yu, Ruidi, Desai, Aakash, Li, Chunrui, Gao, Qinglei

“…Patients with malignancy were reportedly more susceptible and vulnerable to Coronavirus Disease 2019 (COVID-19), and witnessed a greater mortality risk in…”
Get full text

Risk factors for developing into critical COVID-19 patients in Wuhan, China: A multicenter, retrospective, cohort study by Liu, Dan, Cui, Pengfei, Zeng, Shaoqing, Wang, Siyuan, Feng, Xinxia, Xu, Sen, Li, Ruyuan, Gao, Yue, Yu, Ruidi, Wang, Ya, Yuan, Yuan, Li, Huayi, Jiao, Xiaofei, Chi, Jianhua, Liu, Jiahao, Yu, Yang, Zheng, Xu, Song, Chunyan, Jin, Ning, Gong, Wenjian, Liu, Xingyu, Cai, Guangyao, Li, Chunrui, Gao, Qinglei

“…The ferocious global assault of COVID-19 continues. Critically ill patients witnessed significantly higher mortality than severe and moderate ones. Herein, we…”
Get full text

CD19/CD22 CAR-T-cell cocktail therapy following autologous transplantation is an optimizing strategy for treating relapsed/refractory central nervous system lymphoma by Zhou, Xiaoxi, Yu, Qiuxia, Dai, Zigang, Wang, Jue, Li, Chunrui, Huang, Liang, Zhang, Yicheng, Cao, Yang

“…Relapsed/refractory (R/R) primary and secondary central nervous system lymphomas (PCNSL, SCNSL) are associated with short survival and represent an unmet need,…”
Get full text

A Model Perspective Explanation of the Long-Term Sustainability of a Fully Human BCMA-Targeting CAR (CT103A) T-Cell Immunotherapy by Mu, Wei, Long, Xiaolu, Cai, Haodong, Chen, Caixia, Hu, Guang, Lou, Yaoyao, Xing, Shugang, Wang, Di, Wang, Jue, Xiao, Min, Wang, Kun, Sun, Zhongyi, Li, Chunrui, Zhou, Jianfeng, Chen, Liting

“…Different from canonical drugs, CAR T-cells are "living drugs", which derived from patient's own blood. Studies of the pharmacokinetics of CAR T-cells could…”
Get full text

A phase I study of anti‐BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia by Li, Chunrui, Cao, Wenyue, Que, Yimei, Wang, Qiuxiang, Xiao, Yi, Gu, Chaojiang, Wang, Di, Wang, Jue, Jiang, Lijun, Xu, Hao, Xu, Jinhuan, Zhou, Xiaoxi, Hong, Zhenya, Wang, Na, Huang, Liang, Zhang, Shangkun, Chen, Liting, Mao, Xia, Xiao, Min, Zhang, Wei, Meng, Li, Cao, Yang, Zhang, Tongcun, Li, Jian, Zhou, Jianfeng

“…Background Relapsed/refractory (R/R) multiple myeloma (MM) patients and primary plasma cell leukemia (PCL) have an unfavorable prognosis and no effective…”
Get full text